Cargando…

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis

OBJECTIVE: Uncontrolled studies of mesenchymal stem cells (MSCs) in multiple sclerosis suggested some beneficial effect. In this randomized, double-blind, placebo-controlled, crossover phase II study we investigated their safety and efficacy in relapsing-remitting multiple sclerosis patients. Effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llufriu, Sara, Sepúlveda, María, Blanco, Yolanda, Marín, Pedro, Moreno, Beatriz, Berenguer, Joan, Gabilondo, Iñigo, Martínez-Heras, Eloy, Sola-Valls, Nuria, Arnaiz, Joan-Albert, Andreu, Enrique J., Fernández, Begoña, Bullich, Santi, Sánchez-Dalmau, Bernardo, Graus, Francesc, Villoslada, Pablo, Saiz, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250058/ https://www.ncbi.nlm.nih.gov/pubmed/25436769 http://dx.doi.org/10.1371/journal.pone.0113936

Ejemplares similares

Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study
por: Llufriu, Sara, et al.
Publicado: (2012)

Vanishing spinal cord after varicella-zoster virus myelitis
por: Sepúlveda, María, et al.
Publicado: (2017)

Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis
por: Solana, Elisabeth, et al.
Publicado: (2018)

Structural networks involved in attention and executive functions in multiple sclerosis
por: Llufriu, Sara, et al.
Publicado: (2016)

Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
por: Solana, Elisabeth, et al.
Publicado: (2021)

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis
por: Sola-Valls, Nuria, et al.
Publicado: (2019)

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine
por: Sola-Valls, Núria, et al.
Publicado: (2018)

Liver injury and glatiramer acetate, an uncommon association: case report and literature review
por: Almeida, Javier, et al.
Publicado: (2017)

The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
por: Martínez-Lapiscina, Elena H, et al.
Publicado: (2014)

Abnormal Control of Orbicularis Oculi Reflex Excitability in Multiple Sclerosis
por: Cabib, Christopher, et al.
Publicado: (2014)

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
por: Sepulveda, Maria, et al.
Publicado: (2019)

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients
por: Roura, Eloy, et al.
Publicado: (2021)

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years
por: Pulido-Valdeolivas, Irene, et al.
Publicado: (2020)

Impact of Cognitive Reserve and Structural Connectivity on Cognitive Performance in Multiple Sclerosis
por: Lopez-Soley, Elisabet, et al.
Publicado: (2020)

Modified connectivity of vulnerable brain nodes in multiple sclerosis, their impact on cognition and their discriminative value
por: Solana, Elisabeth, et al.
Publicado: (2019)

Predictors of vision impairment in Multiple Sclerosis
por: Sanchez-Dalmau, Bernardo, et al.
Publicado: (2018)

Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI
por: Martínez-Heras, Eloy, et al.
Publicado: (2020)

Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
por: Sepúlveda, Maria, et al.
Publicado: (2021)

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
por: Lopez-Soley, Elisabet, et al.
Publicado: (2021)

Antibody Repertoire in Paraneoplastic Cerebellar Degeneration and Small Cell Lung Cancer
por: Sabater, Lidia, et al.
Publicado: (2013)

The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested
por: Ruiz-García, Raquel, et al.
Publicado: (2020)

Applying multilayer analysis to morphological, structural, and functional brain networks to identify relevant dysfunction patterns
por: Casas-Roma, Jordi, et al.
Publicado: (2022)

Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity
por: Gresa-Arribas, Nuria, et al.
Publicado: (2015)

Improved Framework for Tractography Reconstruction of the Optic Radiation
por: Martínez-Heras, Eloy, et al.
Publicado: (2015)

Clinically reversible ustekinumab-induced encephalopathy: case report and review of the literature
por: Sarto, Jordi, et al.
Publicado: (2022)

Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center
por: Ariño, Helena, et al.
Publicado: (2023)

An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays
por: Höftberger, Romana, et al.
Publicado: (2013)

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
por: Zubizarreta, Irati, et al.
Publicado: (2019)

In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis
por: Alba-Arbalat, Salut, et al.
Publicado: (2021)

Clinical significance of Kelch-like protein 11 antibodies
por: Maudes, Estibaliz, et al.
Publicado: (2020)

Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)

Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
por: Ruiz-García, Raquel, et al.
Publicado: (2021)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies
por: Höftberger, Romana, et al.
Publicado: (2012)

Susac Syndrome: Description of a Single-Centre Case Series
por: Beça, Sara, et al.
Publicado: (2022)

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies
por: Arnaldos-Pérez, Cristina, et al.
Publicado: (2023)

Pollutant Concentration Changes During the COVID-19 Lockdown in Barcelona and Surrounding Regions: Modification of Diurnal Cycles and Limited Role of Meteorological Conditions
por: García-Dalmau, Miguel, et al.
Publicado: (2021)

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8qd1es52o0njfu8k6dsi9dipij